CIBC Asset Management
LBPH

CIBC Asset Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

CIBC Asset Management’s Portfolio LBPH Stock Details LBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-343,012
Closed -$11.4M – 1313
2024
Q3 		$11.4M Buy
343,012
+30
+0% +$1.03K 0.04% 260
2024
Q2 		$9.27M Buy
342,982
+856
+0.3% +$16.9K 0.03% 274
2024
Q1 		$7.39M Buy
342,126
+129,948
+61% +$2.83M 0.03% 326
2023
Q4 		$1.28M Buy
212,178
+67,607
+47% +$337K ﹤0.01% 629
2023
Q3 		$804K Hold
144,571
– – ﹤0.01% 672
2023
Q2 		$1.06M Buy
144,571
+88,446
+158% +$670K ﹤0.01% 649
2023
Q1 		$225K Buy
+56,125
New +$274K ﹤0.01% 899

CIBC Asset Management's LBPH Position: Q4 2024 in Review

CIBC Asset Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 343,012 shares — an estimated $11.4M sold.

CIBC Asset Management first reported a position in LBPH in Q1 2023 and held it in 7 quarters. The position peaked at $11.4M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • CIBC Asset Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • CIBC Asset Management sold 343,012 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $11.4M.
  • CIBC Asset Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
  • CIBC Asset Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $11.4M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on CIBC Asset Management's 13F filing for Q4 2024, filed 31 Jan 2025.